subscribeSubscribe
Avenacy launches Tranexamic Acid Injection, USP in the U.S. market.

Avenacy launches Tranexamic Acid Injection, USP in the U.S. market.
BUSINESSWIRE
24 Jun 2024
Share Share
Rubicon`s Generic Tranexamic Acid Receives Approval in US

Rubicon`s Generic Tranexamic Acid Receives Approval in US
FDA
11 Jun 2024
Share Share
Nexus` Generic Tranexamic Acid Receives Approval in the U.S.

Nexus` Generic Tranexamic Acid Receives Approval in the U.S.

FDA
16 Apr 2024
Share Share
Gland Pharma`s Generic Tranexamic Acid Receives Approval in the U.S

Gland Pharma`s Generic Tranexamic Acid Receives Approval in the U.S
FDA
16 Apr 2024
Share Share
Enforcement Report - Week of October 12, 2022

Enforcement Report - Week of October 12, 2022
FDA
12 Oct 2022
Share Share
Hyloris Reports Positive Phase 1 Data for HY-004

Hyloris Reports Positive Phase 1 Data for HY-004
GLOBENEWSWIRE
20 Jul 2022
Share Share
Amring Pharmaceuticals Inc. Licenses LYSTEDA to Pierre Fabre for Mexican Market

Amring Pharmaceuticals Inc. Licenses LYSTEDA to Pierre Fabre for Mexican Market
BUSINESSWIRE
29 Sep 2021
Share Share
Received CEP approval for Tranexamic Acid

Received CEP approval for Tranexamic Acid
PRESS RELEASE
18 Aug 2021
Share Share
Tranexamic Acid Mouthwash Failure update: Presented at ISTH

Tranexamic Acid Mouthwash Failure update: Presented at ISTH
PIOS
23 Jul 2021
Share Share
FDA: Risk of Inadvertent Intrathecal Administration of Tranexamic Acid Injection

FDA: Risk of Inadvertent Intrathecal Administration of Tranexamic Acid Injection
Brian Park BUSINESSWIRE
04 Dec 2020
Share Share